Search Results - "Olujohungbe, A."

Refine Results
  1. 1
  2. 2

    Priapism in sickle‐cell disease; incidence, risk factors and complications – an international multicentre study by Adeyoju, A.B., Olujohungbe, A.B.K., Morris, J., Yardumian, A., Bareford, D., Akenova, A., Akinyanju, O., Cinkotai, K., O'Reilly, P.H.

    Published in BJU international (01-12-2002)
    “…Objective  To define the incidence, risk factors and complications of priapism in a large population of patients with sickle‐cell anaemia in five centres in…”
    Get full text
    Journal Article
  3. 3

    ‘Microalbuminuric anaemia’—The relationship between haemoglobin levels and albuminuria in diabetes by Adetunji, O.R, Mani, H, Olujohungbe, A, Abraham, K.A, Gill, G.V

    Published in Diabetes research and clinical practice (01-08-2009)
    “…Abstract Background There is an increasing incidence of anaemia in diabetes despite the absence of significant renal impairment. Aims This study set out to…”
    Get full text
    Journal Article
  4. 4

    Hydroxyurea for sickle cell disease by Davies, S, Olujohungbe, A

    “…Sickle cell disease is one of the most common inherited diseases world wide. It is associated with life long morbidity and a reduced life expectancy…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Does erythropoietin accelerate malignant transformation in multiple myeloma? by Olujohungbe, A., Handa, S., Holmes, J.

    Published in Postgraduate medical journal (01-03-1997)
    “…Growth factors or humoral agents can support haemopoiesis in various bone marrow disorders. They have the ability to act on multiple cell lineages and in…”
    Get full text
    Journal Article
  10. 10

    The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke by CUMMING, A. M, OLUJOHUNGBE, A, KEENEY, S, SINGH, H, HAY, C. R. M, SERJEANT, G. R

    Published in British journal of haematology (01-12-1999)
    “…Homozygosity for the methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism may cause hyperhomocysteinaemia, a recognized risk factor for stroke,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hydroxyurea therapy for sickle cell disease in Britain by Olujohungbe, A, Cinkotai, Kornelia I, Yardumian, A

    Published in BMJ (06-06-1998)
    “…With appropriate monitoring, side effects are few, and pilot schemes using hydroxyurea in children with sickle cell disease have now been reported from America…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Register cannot replace prospective studies in sickle cell disease by Yardumian, A, Olujohungbe, A, Cinkotai, K

    Published in BMJ (06-03-1999)
    “…EDITOR-We welcome the launch of a European register of patients with sickle cell disease treated with hydroxyurea 1 and will certainly offer anonymised details…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20